Jiwei Guo

1.9k total citations · 1 hit paper
21 papers, 615 citations indexed

About

Jiwei Guo is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jiwei Guo has authored 21 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Jiwei Guo's work include Metabolomics and Mass Spectrometry Studies (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Jiwei Guo is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Jiwei Guo collaborates with scholars based in China and United States. Jiwei Guo's co-authors include Lijuan Yang, Juanjuan Dai, Jing Du, Kaikai Gong, Shuang Miao, Weiwei Chen, Dan Jin, Yan Wu, Xiaohong Wang and Hongliang Sun and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Oncotarget.

In The Last Decade

Jiwei Guo

20 papers receiving 607 citations

Hit Papers

m6A demethylase ALKBH5 inhibits tumor growth and metastas... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC
    2020 271 citations Dan Jin, Jiwei Guo et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwei Guo China 11 507 297 50 45 44 21 615
Chunjie Yu China 10 435 0.9× 175 0.6× 50 1.0× 45 1.0× 27 0.6× 18 511
Lvjia Zhuo China 7 493 1.0× 273 0.9× 41 0.8× 69 1.5× 39 0.9× 8 577
Lina Romero United States 11 327 0.6× 261 0.9× 93 1.9× 45 1.0× 148 3.4× 13 606
Yuanchang Hu China 9 379 0.7× 221 0.7× 71 1.4× 28 0.6× 35 0.8× 14 502
Xuyang Hou China 12 304 0.6× 140 0.5× 69 1.4× 21 0.5× 46 1.0× 22 410
Yuejie Lu China 9 545 1.1× 428 1.4× 71 1.4× 26 0.6× 104 2.4× 15 678
Kaifang Ma China 11 432 0.9× 323 1.1× 87 1.7× 36 0.8× 150 3.4× 28 614

Countries citing papers authored by Jiwei Guo

Since Specialization
Citations

This map shows the geographic impact of Jiwei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwei Guo more than expected).

Fields of papers citing papers by Jiwei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwei Guo. The network helps show where Jiwei Guo may publish in the future.

Co-authorship network of co-authors of Jiwei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwei Guo. A scholar is included among the top collaborators of Jiwei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwei Guo. Jiwei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Jing, Dongli Hu, Yu Cheng, et al.. (2021). Lipidomics and transcriptomics analyses of altered lipid species and pathways in oxaliplatin-treated colorectal cancer cells. Journal of Pharmaceutical and Biomedical Analysis. 200. 114077–114077. 10 indexed citations
3.
Wang, Zhibin, Shilong Jiang, Shaobo Liu, et al.. (2021). Metabolomics of Artichoke Bud Extract in Spontaneously Hypertensive Rats. ACS Omega. 6(29). 18610–18622. 6 indexed citations
4.
Guo, Jiwei, Jing Yu, Feng Peng, et al.. (2021). In vitro and in vivo analysis of metabolites involved in the TCA cycle and glutamine metabolism associated with cisplatin resistance in human lung cancer. Expert Review of Proteomics. 18(3). 233–240. 9 indexed citations
5.
Wang, Xiaohong, Kai Cheng, Guoqiang Zhang, et al.. (2020). Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance. Frontiers in Oncology. 10. 960–960. 43 indexed citations
6.
Jin, Dan, Jiwei Guo, Yan Wu, et al.. (2020). m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2–mediated YAP activity in NSCLC. Molecular Cancer. 19(1). 40–40. 271 indexed citations breakdown →
7.
Liu, Tong, Jing Yu, Feng Peng, et al.. (2020). A conjunctive lipidomic approach reveals plasma ethanolamine plasmalogens and fatty acids as early diagnostic biomarkers for colorectal cancer patients. Expert Review of Proteomics. 17(3). 233–242. 28 indexed citations
8.
Gong, Kaikai, Shuang Miao, Lijuan Yang, et al.. (2020). Aaptamine attenuates the proliferation and progression of non-small cell lung carcinoma. Pharmaceutical Biology. 58(1). 1044–1054. 15 indexed citations
9.
Sun, Leitao, Wensheng Zhang, Zefu Li, et al.. (2019). The expression of cerebrospinal fluid exosomal miR-630 plays an important role in the dysfunction of endothelial cells after subarachnoid hemorrhage. Scientific Reports. 9(1). 11510–11510. 20 indexed citations
10.
Wang, Xiaohong, Yong Han, Jian Liu, et al.. (2019). Exosomes Play an Important Role in the Progression of Plasma Cell Mastitis via the PI3K-Akt-mTOR Signaling Pathway. Mediators of Inflammation. 2019. 1–11. 15 indexed citations
11.
Chen, Weiwei, Jiajia An, Jiwei Guo, et al.. (2018). Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness. Cancer Chemotherapy and Pharmacology. 81(5). 885–895. 19 indexed citations
12.
Guo, Jiwei, Yan Wu, Jing Du, et al.. (2018). Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression. Oncogenesis. 7(6). 49–49. 86 indexed citations
13.
Zhang, Qian, et al.. (2018). Biomaterial suture Vicryl Plus reduces wound-related complications. Therapeutics and Clinical Risk Management. Volume 14. 1417–1421. 6 indexed citations
14.
Du, Jing, Weiwei Chen, Lijuan Yang, et al.. (2017). Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatment. Scientific Reports. 7(1). 1899–1899. 20 indexed citations
15.
16.
Guo, Jiwei, Yan Wu, Lijuan Yang, et al.. (2016). Repression of YAP by NCTD disrupts NSCLC progression. Oncotarget. 8(2). 2307–2319. 37 indexed citations
17.
Guo, Jiwei & Dan Jin. (2015). A genetic screen in Drosophila implicates Sex comb on midleg (Scm) in tissue overgrowth and mechanisms of Scm degradation by Wds. Mechanisms of Development. 136. 1–7. 4 indexed citations
18.
Guo, Jiwei, et al.. (2014). [Association between levels of serum leptin and insulin resistance in patients with polycystic ovary syndrome].. PubMed. 35(12). 1389–91. 9 indexed citations
19.
Guo, Jiwei, et al.. (1995). Treatment of primary trigeminal neuralgia with acupuncture at the sphenopalatine ganglion.. PubMed. 15(1). 31–3. 3 indexed citations
20.
Jankowska−Gan, Ewa, Kevin T. Hogan, Jiwei Guo, et al.. (1993). Epitope fine specificity of human anti-HLA-A2 antibodies identification of four epitopes including a haptenlike epitope on HLA-A2 at lysine 127. Human Immunology. 37(3). 165–177. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunjie Yu Breakdown of academic impact, for papers by Lvjia Zhuo Breakdown of academic impact, for papers by Lina Romero Breakdown of academic impact, for papers by Yuanchang Hu Breakdown of academic impact, for papers by Xuyang Hou Breakdown of academic impact, for papers by Yuejie Lu Breakdown of academic impact, for papers by Kaifang Ma
Rankless by CCL
2026